301103 何氏眼科
已收盘 10-16 15:00:00
资讯
新帖
简况
何氏眼科（301103）披露转回资产减值准备公告，10月15日股价下跌2.31%
证券之星 · 10-15 22:52
何氏眼科（301103）披露转回资产减值准备公告，10月15日股价下跌2.31%
何氏眼科（301103）披露变更部分募集资金专项账户并重新签订三方监管协议公告，10月14日股价下跌2.61%
证券之星 · 10-14 22:41
何氏眼科（301103）披露变更部分募集资金专项账户并重新签订三方监管协议公告，10月14日股价下跌2.61%
何氏眼科（301103）9月29日主力资金净买入551.79万元
证券之星 · 09-30
何氏眼科（301103）9月29日主力资金净买入551.79万元
股市必读：何氏眼科（301103）9月11日披露最新机构调研信息
证券之星 · 09-14
股市必读：何氏眼科（301103）9月11日披露最新机构调研信息
何氏眼科：9月11日召开业绩说明会，投资者参与
证券之星 · 09-11
何氏眼科：9月11日召开业绩说明会，投资者参与
何氏眼科（301103）新增【医美】概念
证券之星 · 09-08
何氏眼科（301103）新增【医美】概念
股市必读：何氏眼科（301103）9月7日董秘有最新回复
证券之星 · 09-08
股市必读：何氏眼科（301103）9月7日董秘有最新回复
何氏眼科：关于本次境外收购项目，公司一直在全力推进境内投资审批备案相关工作
证券之星 · 09-07
何氏眼科：关于本次境外收购项目，公司一直在全力推进境内投资审批备案相关工作
何氏眼科（301103）2026年中报简析：增收不增利，公司应收账款体量较大
证券之星 · 08-29
何氏眼科（301103）2026年中报简析：增收不增利，公司应收账款体量较大
何氏眼科(301103)6月30日股东户数0.97万户，较上期减少0.52%
证券之星 · 08-27
何氏眼科(301103)6月30日股东户数0.97万户，较上期减少0.52%
何氏眼科2026年半年报：屈光业务放量，表观净利承压
蓝鲸财经 · 08-27
何氏眼科2026年半年报：屈光业务放量，表观净利承压
何氏眼科(301103.SZ)发布上半年业绩，归母净利润4153.33万元，同比下降6.30%
智通财经 · 08-27
何氏眼科(301103.SZ)发布上半年业绩，归母净利润4153.33万元，同比下降6.30%
何氏眼科（301103）披露董事会换届选举结果，8月6日股价下跌0.12%
证券之星 · 08-06
何氏眼科（301103）披露董事会换届选举结果，8月6日股价下跌0.12%
何氏眼科：选举李丽娟为职工代表董事
财中社 · 08-06
何氏眼科：选举李丽娟为职工代表董事
何氏眼科（301103）披露董事会换届选举议案，7月21日股价下跌3.13%
证券之星 · 07-21
何氏眼科（301103）披露董事会换届选举议案，7月21日股价下跌3.13%
何氏眼科：参股产业基金聚焦眼科产业链上下游核心领域
证券之星 · 07-02
何氏眼科：参股产业基金聚焦眼科产业链上下游核心领域
何氏眼科跌3.1% 2022年上市募13亿元中原证券保荐
中金财经 · 06-30
何氏眼科跌3.1% 2022年上市募13亿元中原证券保荐
何氏眼科：目前未涉及开展眼科手术机器人自研工作
证券之星 · 06-17
何氏眼科：目前未涉及开展眼科手术机器人自研工作
何氏眼科：公司管理层努力做好经营和管理
证券之星 · 06-15
何氏眼科：公司管理层努力做好经营和管理
何氏眼科：持续夯实眼科主业
证券之星 · 06-05
何氏眼科：持续夯实眼科主业
加载更多
公司概况
公司名称：
辽宁何氏眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2022-03-22
主营业务：
辽宁何氏眼科医院集团股份有限公司的主营业务是向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要产品是白内障诊疗服务、屈光不正手术矫正服务、玻璃体视网膜诊疗服务、其他手术诊疗服务项目。
发行价格：
42.50
{"stockData":{"symbol":"301103","market":"SZ","secType":"STK","nameCN":"何氏眼科","latestPrice":16.13,"timestamp":1792134210000,"preClose":16.06,"halted":0,"volume":1762200,"delay":0,"changeRate":0.0044,"floatShares":122000000,"shares":158000000,"eps":0.1554,"marketStatus":"已收盘","change":0.07,"latestTime":"10-16 15:00:00","open":16.17,"high":16.6,"low":15.98,"amount":28842400,"amplitude":0.0386,"askPrice":16.16,"askSize":127,"bidPrice":16.08,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.1554,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.06,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":17.67,"lowLimit":14.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":158026471,"isCdr":false,"pbRate":1.33,"roa":"--","peRate":103.796654,"roe":"2.18%","epsLYR":0.173,"committee":-0.453901,"marketValue":2549000000,"turnoverRate":0.0145,"status":0,"floatMarketCap":1962000000},"requestUrl":"/m/hq/s/301103","defaultTab":"news","newsList":[{"id":"2675355755","title":"何氏眼科（301103）披露转回资产减值准备公告，10月15日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355755","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675355755?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:52","pubTimestamp":1792075933,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，何氏眼科报收于16.06元，较前一交易日下跌2.31%，最新总市值为25.38亿元。该股当日开盘16.2元，最高16.35元，最低16.01元，成交额达3008.86万元，换手率为1.53%。公司于2026年10月15日披露《关于转回资产减值准备的公告》。公告显示，辽宁何氏眼科医院集团股份有限公司以2025年12月31日为基准日对各类资产进行减值测试，并根据结果计提资产减值准备。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500040013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675032804","title":"何氏眼科（301103）披露变更部分募集资金专项账户并重新签订三方监管协议公告，10月14日股价下跌2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675032804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675032804?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:41","pubTimestamp":1791988870,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，何氏眼科报收于16.44元，较前一交易日下跌2.61%，最新总市值为25.98亿元。该股当日开盘16.81元，最高16.81元，最低16.31元，成交额达3063.57万元，换手率为1.53%。公告显示，辽宁何氏眼科医院集团股份有限公司因变更募集资金专项账户，重新与中信银行股份有限公司沈阳分行及保荐机构中原证券股份有限公司签订募集资金三方监管协议。原专户资金本息余额已转存至新专户，原专户将注销，原监管协议终止。董事会已授权财务部办理相关事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400040269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226430","title":"何氏眼科（301103）9月29日主力资金净买入551.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671226430?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:08","pubTimestamp":1790730523,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，何氏眼科报收于17.02元，上涨3.47%，换手率4.25%，成交量5.17万手，成交额8875.66万元。近5日资金流向一览见下表：何氏眼科融资融券信息显示，融资方面，当日融资买入585.45万元，融资偿还670.41万元，融资净偿还84.96万元。何氏眼科主营业务：面向眼病患者提供眼科专科诊疗服务和视光服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633881","title":"股市必读：何氏眼科（301103）9月11日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667633881?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:27","pubTimestamp":1789331230,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，何氏眼科报收于15.85元，下跌1.98%，换手率1.16%，成交量1.41万手，成交额2238.43万元。当日关注点交易信息汇总：9月11日主力资金净流入46.68万元，占总成交额2.09%。机构调研要点：剔除股权激励费用摊销影响后，2026年上半年归母净利润为4,971.22万元，同比上升12.15%。机构调研要点：公司2025年度现金分红总额占归母净利润的85.52%。2026年上半年屈光手术量同比增长9%，屈光业务收入同比增长16.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057331","title":"何氏眼科：9月11日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057331","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666057331?lang=zh_cn&edition=full","pubTime":"2026-09-11 23:04","pubTimestamp":1789139075,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月11日何氏眼科发布公告称公司于2026年9月11日召开业绩说明会。何氏眼科主营业务：面向眼病患者提供眼科专科诊疗服务和视光服务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665789623","title":"何氏眼科（301103）新增【医美】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2665789623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665789623?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:30","pubTimestamp":1788870621,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，9月8日何氏眼科新增概念。何氏眼科主营业务：面向眼病患者提供眼科专科诊疗服务和视光服务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800034032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665310322","title":"股市必读：何氏眼科（301103）9月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2665310322","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665310322?lang=zh_cn&edition=full","pubTime":"2026-09-08 00:55","pubTimestamp":1788800114,"startTime":"0","endTime":"0","summary":"截至2026年9月7日收盘，何氏眼科报收于16.41元，上涨0.0%，换手率1.0%，成交量1.21万手，成交额1992.62万元。关于本次境外收购项目，公司一直在全力推进境内投资审批备案相关工作，目前各项相关工作仍在有序开展。公司将严格按照监管规定，在事项出现重大进展或重大变化时及时履行信息披露义务，请关注公司公告，注意投资风险。当日关注点交易信息汇总：9月7日主力资金净流出120.29万元，占总成交额6.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800000500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665316929","title":"何氏眼科：关于本次境外收购项目，公司一直在全力推进境内投资审批备案相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2665316929","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665316929?lang=zh_cn&edition=full","pubTime":"2026-09-07 16:33","pubTimestamp":1788769987,"startTime":"0","endTime":"0","summary":"证券之星消息，何氏眼科(301103)09月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司收购日本医道进展如何了，距离披露此事项快一年了，存在什么阻碍，还没有相关进展的公告或说明。何氏眼科回复：尊敬的投资者您好！关于本次境外收购项目，公司一直在全力推进境内投资审批备案相关工作，目前各项相关工作仍在有序开展。公司将严格按照监管规定，在事项出现重大进展或重大变化时及时履行信息披露义务，请关注公司公告，注意投资风险。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700020965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016266","title":"何氏眼科（301103）2026年中报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016266?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:50","pubTimestamp":1787957430,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期何氏眼科发布2026年中报。截至本报告期末，公司营业总收入5.85亿元，同比上升4.46%，归母净利润4153.33万元，同比下降6.3%。本报告期何氏眼科公司应收账款体量较大，当期应收账款占最新年报归母净利润比达113.48%。本次财报公布的各项数据指标表现一般。财报体检工具显示：建议关注公司应收账款状况本文数据来源于何氏眼科2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662070305","title":"何氏眼科(301103)6月30日股东户数0.97万户，较上期减少0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662070305","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662070305?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:18","pubTimestamp":1787825888,"startTime":"0","endTime":"0","summary":"证券之星消息，近日何氏眼科披露，截至2026年6月30日公司股东户数为9715.0户，较3月31日减少51.0户，减幅为0.52%。在医疗服务行业个股中，何氏眼科股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.75万户。从股价来看，2026年3月31日至2026年6月30日，何氏眼科区间跌幅为23.09%，在此期间股东户数减少51.0户，减幅为0.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703852","title":"何氏眼科2026年半年报：屈光业务放量，表观净利承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703852","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703852?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:06","pubTimestamp":1787825170,"startTime":"0","endTime":"0","summary":"报告期内，屈光业务表现亮眼，实现收入1.58亿元，同比增长16.66%，毛利率提升1.39个百分点至54.94%，主要得益于全飞秒、ICL等高端术式推广及手术量同比增长9%。相比之下，受医保控费及耗材集采常态化影响，白内障诊疗收入同比下降7.16%，毛利率下降5.32个百分点至35.04%。后续需重点关注屈光手术量的持续性及加盟店转化效率，以及医保政策变化对白内障等基础业务毛利率的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787818380445418719","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662777929","title":"何氏眼科(301103.SZ)发布上半年业绩，归母净利润4153.33万元，同比下降6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662777929","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662777929?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:23","pubTimestamp":1787822597,"startTime":"0","endTime":"0","summary":"智通财经APP讯，何氏眼科(301103.SZ)发布2026年半年度报告，报告期内，公司实现营业收入5.85亿元，同比增长4.46%。实现归属于上市公司股东的净利润4153.33万元，同比下降6.30%。实现归属于上市公司股东的扣除非经常性损益的净利润3475.93万元，同比下降6.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658642","title":"何氏眼科（301103）披露董事会换届选举结果，8月6日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657658642?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:45","pubTimestamp":1786027518,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，何氏眼科报收于16.09元，较前一交易日下跌0.12%，最新总市值为25.43亿元。该股当日开盘16.05元，最高16.19元，最低15.87元，成交额达2705.07万元，换手率为1.39%。公司于近日披露《2026年第三次临时股东会决议公告》，显示辽宁何氏眼科医院集团股份有限公司于2026年8月6日召开2026年第三次临时股东会，会议采用现场与网络投票相结合方式，审议通过董事会换届选举议案。出席会议股东共32人，代表有表决权股份总数的54.5608%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600040203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636512","title":"何氏眼科：选举李丽娟为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636512","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657636512?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:29","pubTimestamp":1786015740,"startTime":"0","endTime":"0","summary":"8月6日，何氏眼科（301103）发布公告，公司召开职工代表大会，选举李丽娟为第四届董事会职工代表董事。2026年一季度，何氏眼科实现收入3.05亿元，归母净利润3269万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-06/doc-inimksmf3808276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653248205","title":"何氏眼科（301103）披露董事会换届选举议案，7月21日股价下跌3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653248205","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653248205?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:32","pubTimestamp":1784644363,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，何氏眼科报收于15.18元，较前一交易日下跌3.13%，最新总市值为23.99亿元。该股当日开盘15.63元，最高15.66元，最低14.8元，成交额达5054.68万元，换手率为2.75%。近日，辽宁何氏眼科医院集团股份有限公司披露《关于召开2026年第三次临时股东会的通知》。股权登记日为2026年8月3日，登记时间截至2026年8月4日。中小投资者投票结果将单独统计披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648500959","title":"何氏眼科：参股产业基金聚焦眼科产业链上下游核心领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2648500959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648500959?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:48","pubTimestamp":1782996487,"startTime":"0","endTime":"0","summary":"证券之星消息，何氏眼科07月01日在投资者关系平台上答复投资者关心的问题。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200039466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647053994","title":"何氏眼科跌3.1% 2022年上市募13亿元中原证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2647053994","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647053994?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:03","pubTimestamp":1782810195,"startTime":"0","endTime":"0","summary":"中国经济网北京6月30日讯 何氏眼科 今日收报14.98元，跌幅3.10%。 何氏眼科首次公开发行股票的发行费用总额为13,193.87万元，其中，保荐承销费用9,990.49万元。 何氏眼科披露的2021年度分红派息、转增股本实施公告显示，公司于2022年5月19日召开的2021年年度股东大会审议通过了《关于2021年度利润分配及资本公积金转增股本预案的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260630/32294805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601375","BK0201","BK0276","BK0236","IPOS","301103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746036","title":"何氏眼科：目前未涉及开展眼科手术机器人自研工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644746036?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:52","pubTimestamp":1781700722,"startTime":"0","endTime":"0","summary":"证券之星消息，何氏眼科(301103)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：何总：公司的眼科机器人什么情况？何氏眼科回复：尊敬的投资者您好，公司高度重视智慧医疗与数字化建设，目前未涉及开展眼科手术机器人自研工作。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700039433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643899275","title":"何氏眼科：公司管理层努力做好经营和管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2643899275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643899275?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:45","pubTimestamp":1781509522,"startTime":"0","endTime":"0","summary":"证券之星消息，何氏眼科(301103)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问：何总:公司股价已逼近净资产价格了？有考虑采取措施维护二级市场稳定吗？何氏眼科回复：尊敬的投资者您好！公司股价的波动受市场整体情绪、行业板块轮动、资金偏好等多重因素综合影响。短期市场表现不一定完全匹配公司内在价值。公司管理层努力做好经营和管理，依法合规并积极探索行之有效的市值管理方式和路径，持续提升公司内在价值，为股东及利益相关方谋求长期稳定的投资回报。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500014679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301103","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148409","title":"何氏眼科：持续夯实眼科主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641148409?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:48","pubTimestamp":1780663689,"startTime":"0","endTime":"0","summary":"证券之星消息，何氏眼科06月04日在投资者关系平台上答复投资者关心的问题。公司坚信，扎实经营、兑现股权激励业绩考核目标，是从基本面支撑长期价值、保障股权激励实效、稳固员工信心的根本路径。如后续出台相关计划，将严格按照法律法规及交易所规则，履行决策程序并及时披露相关信息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500038638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","301103"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792194613314,"stockEarnings":[{"period":"1week","weight":-0.0611},{"period":"1month","weight":0.0267},{"period":"3month","weight":0.0138},{"period":"6month","weight":-0.15},{"period":"1year","weight":-0.2175},{"period":"ytd","weight":-0.1708}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁何氏眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"9715人(较上一季度减少0.52%)","perCapita":"12520股","listingDate":"2022-03-22","address":"辽宁省沈阳市浑南区天赐街5-1号(607)","registeredCapital":"15802万元","survey":" 辽宁何氏眼科医院集团股份有限公司的主营业务是向眼病患者提供眼科专科诊疗服务和视光服务。公司的主要产品是白内障诊疗服务、屈光不正手术矫正服务、玻璃体视网膜诊疗服务、其他手术诊疗服务项目。","listedPrice":42.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"何氏眼科,301103,何氏眼科股票,何氏眼科股票老虎,何氏眼科股票老虎国际,何氏眼科行情,何氏眼科股票行情,何氏眼科股价,何氏眼科股市,何氏眼科股票价格,何氏眼科股票交易,何氏眼科股票购买,何氏眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"何氏眼科(301103)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供何氏眼科(301103)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}